Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrine Tumors
•
Endocrinology
Does octreotide therapy interfere with the ability to localize an insulinoma via radionuclide diagnostic studies?
Related Questions
Is tall cell variant papillary thyroid cancer automatically categorized as intermediate risk regardless of other histopathological features and should consequently be treated with RAI?
How do you evaluate/treat a patient with minimal papillary thyroid cancer foci in ovarian mature teratoma tissue (after an oophorectomy) that does not meet criteria for struma ovarii diagnosis?
Can carbamazepine make thyroid function test results look spuriously abnormal?
Is Evenity appropriate for a patient with severe osteoporosis (T-score -3.1) unresponsive to bisphosphonates and persistent primary hyperparathyroidism despite two surgeries?
Should we aim to reduce or stop thiazides in patients with thiazide-induced hypercalcemia given its similar risk profile to untreated primary hyperparathyroidism?
What are your thoughts on the possible correlation between Breast implants and thyroid autoimmune disorders / or thyroid cancer?
Do you recommend early oral nutrition when managing diabetic ketoacidosis?
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
Does the imaging finding of central necrosis of an adrenal tumor, biochemically confirmed as pheochromocytoma, increase the risk of malignancy?
How do you approach treatment of a patient with bilateral adrenal gland thickening & biochemical evidence of ACTH-independent hypercortisolism?
